Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05452447Not ApplicableCompleted

Spatial Repellents for Aedes-borne Virus Control in Sri Lanka

Role: collaborator

NCT06122142Not ApplicableWithdrawn

Spatial Repellents for Malaria Control

Role: collaborator

NCT04766879Not ApplicableCompleted

Spatial Repellents for the Prevention of Malaria in Kenya

Role: collaborator

NCT04795648Not ApplicableCompleted

Spatial Repellents for Vector Control

Role: collaborator

All 4 trials loaded